Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    2.

    Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.

    Xi Y, Riker A, Shevde-Samant L, Samant R, Morris C, Gavin E, Fodstad O, Ju J.

    Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):1-35.PMID: 18359977 [PubMed - indexed for MEDLINE]Related articles

    4.

    The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides.

    Zhang XM, Zhang YF, Huang Y, Qu P, Ma B, Si SY, Li ZS, Li WX, Li X, Ge W, Hu PZ, Sui YF.

    Oncol Rep. 2008 Jul;20(1):245-52.PMID: 18575744 [PubMed - indexed for MEDLINE]Related articles

    5.

    [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production]

    Moiseenko VM, Danilova AB, Danilov AO, Turkevich EA, Baldueva IA, Matsko DE.

    Vopr Onkol. 2008;54(3):303-14. Russian. PMID: 18652234 [PubMed - indexed for MEDLINE]Related articles

    6.

    Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

    Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K.

    Int J Oncol. 2008 Sep;33(3):433-41.PMID: 18695871 [PubMed - indexed for MEDLINE]Related articles

    7.

    Current state of vaccine therapies in non-small-cell lung cancer.

    Romero P.

    Clin Lung Cancer. 2008 Feb;9 Suppl 1:S28-36. Review.PMID: 18540532 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.

    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.

    J Immunother. 2006 Sep-Oct;29(5):545-57.PMID: 16971810 [PubMed - indexed for MEDLINE]Related articles

    9.

    A unified framework for finding differentially expressed genes from microarray experiments.

    Shaik JS, Yeasin M.

    BMC Bioinformatics. 2007 Sep 18;8:347.PMID: 17877806 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.

    Bloethner S, Hemminki K, Thirumaran RK, Chen B, Mueller-Berghaus J, Ugurel S, Schadendorf D, Kumar R.

    Melanoma Res. 2006 Aug;16(4):297-307.PMID: 16845325 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics.

    Zhang JG, Eguchi J, Kruse CA, Gomez GG, Fakhrai H, Schroter S, Ma W, Hoa N, Minev B, Delgado C, Wepsic HT, Okada H, Jadus MR.

    Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):566-75.PMID: 17255279 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: implications for immunotherapy.

    Karanikas V, Tsochas S, Boukas K, Kerenidi T, Nakou M, Dahabreh J, Poularakis T, Gourgoulianis KI, Germenis AE.

    Cancer Biol Ther. 2008 Mar;7(3):345-52. Epub 2007 Dec 13.PMID: 18094614 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities.

    Connerotte T, Van Pel A, Godelaine D, Tartour E, Schuler-Thurner B, Lucas S, Thielemans K, Schuler G, Coulie PG.

    Cancer Res. 2008 May 15;68(10):3931-40.PMID: 18483279 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Expression of melanoma-associated antigens in oral squamous cell carcinoma.

    Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E.

    J Oral Pathol Med. 2008 Feb;37(2):88-93.PMID: 18197853 [PubMed - indexed for MEDLINE]Related articles

    15.

    Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma.

    Dillman RO, DePriest C, DeLeon C, Barth NM, Schwartzberg LS, Beutel LD, Schiltz PM, Nayak SK.

    Cancer Biother Radiopharm. 2007 Jun;22(3):309-21.PMID: 17651037 [PubMed - indexed for MEDLINE]Related articles

    16.

    Carcinoembryonic antigen transgenic mouse models for immunotherapy and development of cancer vaccines.

    Bhattacharya-Chatterjee M, Saha A, Foon KA, Chatterjee SK.

    Curr Protoc Immunol. 2008 Feb;Chapter 20:Unit 20.8. Review.PMID: 18432635 [PubMed - indexed for MEDLINE]Related articles

    17.

    Enhancement of human melanoma antigen expression by IFN-beta.

    Dunn IS, Haggerty TJ, Kono M, Durda PJ, Butera D, Macdonald DB, Benson EM, Rose LB, Kurnick JT.

    J Immunol. 2007 Aug 15;179(4):2134-42.PMID: 17675472 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A Web-based data warehouse on gene expression in human malignant melanoma.

    Györffy B, Lage H.

    J Invest Dermatol. 2007 Feb;127(2):394-9. Epub 2006 Aug 31.PMID: 16946712 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The impact of genomics in understanding human melanoma progression and metastasis.

    Ren S, Liu S, Howell P Jr, Xi Y, Enkemann SA, Ju J, Riker AI.

    Cancer Control. 2008 Jul;15(3):202-15. Review.PMID: 18596672 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.

    Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C.

    Int J Cancer. 2008 Feb 15;122(4):777-84.PMID: 17957795 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data